MEDICO

MEDICO

Pharmaceuticals & Drugs

78.6

0.00 (0.00%)

stock change
Market Cap653 CrEPS0.9High79.35
Stock P/E84.1Net Profit Margin5.7Low77.4
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
explain

Performance

Today’s Low

Today’s High

77.4

79.35

52W Low

52W High

64.55

379.95

Open Price77.4Volume317
Prev. Close77.9
explain

Fundamentals

explain
Market Cap653 CrROE18.0%
P/E Ratio(TTM)84.1EPS(TTM)0.0
P/B Ratio13.7Dividend Yield0.0%
Industry P/E40.7Book Value5.7
Face Value2.0
explain

About the Company

The company was incorporated as Medico Remedies Private Limited on March 18, 1994 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of Company was changed to a public limited company and the name of Company was changed to Medico Remedies Limited by a special resolution passed on January 12, 2017. A fresh Certificate of Incorporation consequent upon conversion was issued on March 06, 2017 by the Registrar of Companies, Mumbai.

They serve wholesalers or traders of formulation products. The company exports its products to Uganda, Myanmar, Vietnam, Cambodia, Dominican Republic, Sri Lanka, Philippines, Turkmenistan, Ghana, Mauritius, Madagascar, Congo, Iraq, Honduras, Cuba, Jamaica, Hong Kong, Nigeria, Senegal, Panama, Mozambique etc. The company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments. Currently, it is engaged in manufacture of formulations for various medicines. Its clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. MRL also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.

Business area of the company:

The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Key Events and Milestones:

  • 1994: Incorporated under Companies Act, 1956 as Medico Remedies Private Limited.
  • 1999: Acquired plot at Palghar for setting up manufacturing set-up for general formulations. 
  • 2002: Acquired plot at Palghar for setting up manufacturing set-up for beta lactam.
  • 2016: Renewed WHO-GMP Certification for their manufacturing facility.
  • 2016: Purchased corporate premises at ‘Hubtown Solaris’.
  • 2017: Renewed ISO-9001:2015 Certification for their manufacturing facility.
  • 2017: Converted into a public limited company and the name of company was changed to Medico Remedies Ltd.
Parent OrganizationMedico Remedies Ltd.Managing DirectorHarshit Mehta
Founded1994NSE SymbolMEDICO
explain

Financials

All values are in Rs Cr

explain

Shareholding Pattern

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

Domestic Institutions

Foreign Institutions

Mutual Funds

Promoters

explain

Peer Comparison

Company52 WeekMarket PriceP/E RatioFinancialsShare Holding
78.6(0.9%)
84.1
29.75(1.5%)
0.0
1026.65(-2.1%)
10.1
305.2(0.0%)
39.3
explain

Recently Viewed

No Recently Viewed Stocks
explain

Frequently asked questions

You can buy the shares of Medico Remedies using the Trinkerr Website or by downloading the Trinkerr app from Android and Apptore.